Literature DB >> 19679518

Visceral organ cross-sensitization - an integrated perspective.

P R Brumovsky1, G F Gebhart.   

Abstract

Viscero-somatic referral and sensitization has been well documented clinically and widely investigated, whereas viscero-visceral referral and sensitization (termed cross-organ sensitization) has only recently received attention as important to visceral disease states. Because second order neurons in the CNS have been extensively shown to receive convergent input from different visceral organs, it has been assumed that cross-organ sensitization arises by the same convergence-projection mechanism as advanced for viscero-somatic referral and sensitization. However, increasing evidence also suggests participation of peripheral mechanisms to explain referral and sensitization. We briefly summarize behavioral, morphological and physiological support of and focus on potential mechanisms underlying cross-organ sensitization. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19679518      PMCID: PMC2818077          DOI: 10.1016/j.autneu.2009.07.006

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  122 in total

1.  Functional cross-excitation between afferent A- and C-neurons in dorsal root ganglia.

Authors:  R Amir; M Devor
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Multiple interacting sites of ectopic spike electrogenesis in primary sensory neurons.

Authors:  Ron Amir; Jeffery D Kocsis; Marshall Devor
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 3.  Neuropeptide tyrosine and pain.

Authors:  Pablo Brumovsky; Tiejun S Shi; Marc Landry; Marcelo J Villar; Tomas Hökfelt
Journal:  Trends Pharmacol Sci       Date:  2007-01-11       Impact factor: 14.819

4.  Neuropeptide Y and calcitonin gene-related peptide modulate voltage-gated Ca2+ channels in mature female rat paracervical ganglion neurons.

Authors:  D P Cohen; S R Ikeda; D L Lewis
Journal:  J Soc Gynecol Investig       Date:  1996 Nov-Dec

5.  A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders.

Authors:  Michael A Pezzone; Ruomei Liang; Matthew O Fraser
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

6.  Changes in urinary bladder smooth muscle function in response to colonic inflammation.

Authors:  R Noronha; H Akbarali; A Malykhina; R D Foreman; Beverley Greenwood-Van Meerveld
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-22

7.  Contrasting effects of WIN 55212-2 on motility of the rat bladder and uterus.

Authors:  Natalia Dmitrieva; Karen J Berkley
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

8.  Vascular protein leakage in the rat parotid gland elicited by reflex stimulation, parasympathetic nerve stimulation and administration of neuropeptides.

Authors:  A Asztély; G Havel; J Ekström
Journal:  Regul Pept       Date:  1998-10-16

Review 9.  Neuropeptides in pelvic afferent pathways.

Authors:  W C de Groat
Journal:  Experientia       Date:  1987-07-15

10.  TRPV1 mediates the uterine capsaicin-induced NMDA NR2B-dependent cross-organ reflex sensitization in anesthetized rats.

Authors:  Hsien-Yu Peng; Hung-Ming Chang; Shin-Da Lee; Pei-Chen Huang; Gin-Den Chen; Cheng-Hung Lai; Cheng-Yuan Lai; Chun-Hsien Chiu; Kwong-Chung Tung; Tzer-Bin Lin
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-16
View more
  49 in total

Review 1.  Do the urinary bladder and large bowel interact, in sickness or in health? ICI-RS 2011.

Authors:  Anna P Malykhina; Jean-Jacques Wyndaele; Karl-Erik Andersson; Stefan De Wachter; Roger R Dmochowski
Journal:  Neurourol Urodyn       Date:  2012-02-29       Impact factor: 2.696

2.  Experimental colitis triggers the release of substance P and calcitonin gene-related peptide in the urinary bladder via TRPV1 signaling pathways.

Authors:  Xiao-Qing Pan; Jessica A Gonzalez; Shaohua Chang; Samuel Chacko; Alan J Wein; Anna P Malykhina
Journal:  Exp Neurol       Date:  2010-05-23       Impact factor: 5.330

3.  Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity.

Authors:  Bo Lian; Louis Vera-Portocarrero; Tamara King; Michael H Ossipov; Frank Porreca
Journal:  Brain Res       Date:  2010-08-19       Impact factor: 3.252

4.  Colonic inflammation up-regulates voltage-gated sodium channels in bladder sensory neurons via activation of peripheral transient potential vanilloid 1 receptors.

Authors:  Q Lei; A P Malykhina
Journal:  Neurogastroenterol Motil       Date:  2012-03-15       Impact factor: 3.598

Review 5.  Does central sensitization help explain idiopathic overactive bladder?

Authors:  W Stuart Reynolds; Roger Dmochowski; Alan Wein; Stephen Bruehl
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

Review 6.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

7.  Neurotrophin signaling and visceral hypersensitivity.

Authors:  Li-Ya Qiao
Journal:  Front Biol (Beijing)       Date:  2014-06

8.  Cystitis increases colorectal afferent sensitivity in the mouse.

Authors:  Pablo Rodolfo Brumovsky; Bin Feng; Linjing Xu; Carly Jane McCarthy; G F Gebhart
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

9.  Bladder outlet obstruction triggers neural plasticity in sensory pathways and contributes to impaired sensitivity in erectile dysfunction.

Authors:  Anna P Malykhina; Qi Lei; Shaohua Chang; Xiao-Qing Pan; Antonio N Villamor; Ariana L Smith; Allen D Seftel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-27       Impact factor: 3.619

Review 10.  Neuroanatomy of lower gastrointestinal pain disorders.

Authors:  Wim Vermeulen; Joris G De Man; Paul A Pelckmans; Benedicte Y De Winter
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.